Rafferty Asset Management’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Rafferty Asset Management’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,732	Closed	-$42K	–	1274
2022 Q2	$42K	Sell	1,732 -34,764	-95%	-$1.18M	﹤0.01%	1110
2022 Q1	$1.82M	Buy	36,496 +8,276	+29%	+$409K	0.01%	636
2021 Q4	$1.98M	Buy	28,220 +11,348	+67%	+$956K	0.01%	665
2021 Q3	$1.57M	Sell	16,872 -337	-2%	-$32K	0.01%	694
2021 Q2	$1.73M	Sell	17,209 -17,175	-50%	-$1.67M	0.01%	728
2021 Q1	$3.21M	Buy	34,384 +24,934	+264%	+$2.53M	0.02%	445
2020 Q4	$780K	Sell	9,450 -11,748	-55%	-$1M	0.01%	577
2020 Q3	$1.82M	Buy	+21,198	New	+$2.47M	0.02%	446

Other funds holding VBIV

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Rafferty Asset Management's VBIV Position: Q3 2022 in Review

Rafferty Asset Management sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2022, closing a stake of 1,732 shares — an estimated $42K sold.

Rafferty Asset Management first reported a position in VBIV in Q3 2020 and held it in 8 quarters. The position peaked at $3.21M in Q1 2021. 127 funds tracked by Wall St. Rank hold VBIV as of Q3 2022.

Rafferty Asset Management reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2022 after selling out during the quarter.
Rafferty Asset Management sold 1,732 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2022, an estimated $42K.
Rafferty Asset Management first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2020 and held it in 8 quarters.
Rafferty Asset Management's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $3.21M in Q1 2021.
127 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2022.

Based on Rafferty Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.